Treatment of Severe Secondary TRIcuspid Regurgitation in Patients With Advance Heart Failure With CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02387697 |
|
Recruitment Status :
Terminated
(Safety concerns)
First Posted : March 13, 2015
Last Update Posted : September 18, 2018
|
Sponsor:
Charite University, Berlin, Germany
Collaborator:
Edwards Lifesciences
Information provided by (Responsible Party):
Prof. Dr. med. Karl Stangl, Charite University, Berlin, Germany
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | May 2018 |
| Actual Study Completion Date : | May 2018 |